Grand Pharmaceutical Group Limited (HKG:0512)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.33
+0.05 (0.80%)
Apr 3, 2025, 4:08 PM HKT
54.01%
Market Cap 22.17B
Revenue (ttm) 11.64B
Net Income (ttm) 2.47B
Shares Out 3.50B
EPS (ttm) 0.70
PE Ratio 8.98
Forward PE 10.46
Dividend 0.26 (4.14%)
Ex-Dividend Date Apr 14, 2025
Volume 11,074,500
Average Volume 15,228,497
Open 6.14
Previous Close 6.28
Day's Range 6.14 - 6.40
52-Week Range 3.83 - 6.49
Beta 0.79
RSI 68.93
Earnings Date Mar 19, 2025

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive... [Read more]

Sector Healthcare
Founded 1995
Employees 11,987
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0512
Full Company Profile

Financial Performance

In 2024, HKG:0512's revenue was 11.64 billion, an increase of 10.59% compared to the previous year's 10.53 billion. Earnings were 2.47 billion, an increase of 31.30%.

Financial Statements

News

There is no news available yet.